MYRIAMED
Live / Registered — Registered (as of 07 May 2024)
What this means for you
Registered since 07 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79350987
- Registration number
- 7376414
- Mark type
- Stylized text
- Filed
- 07 Apr 2022
- Published for opposition
- 20 Feb 2024
- Registered
- 07 May 2024
- Attorney of record
- Michael A. Whittaker
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science, in particular reagents for cultivation of cells and tissue; cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells; biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cells, human fibrotic tissue constructed from stroma cells derived from human induced pluripotent stem cells, connective tissue constructed from connective tissue cells derived from human induced pluripotent stem cells, brain tissue derived from human induced pluripotent stem cells, and neuronal organoids; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes, namely, disease models based on engineered tissue or engineered cells
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, in particular cells and tissues for treatment of cardiac diseases, degenerative muscular diseases, fibrotic diseases, neurodegenerative diseases, connective tissue diseases or disorders with impaired scaring and wound healing; pharmaceutical preparations for the renewal and regeneration of organs; pharmaceutical preparations for use in cellular therapy; biological tissue derived from stem cells for medical purposes; tissue-regenerative pharmaceutical preparations
- Class 009 — Scientific and electric apparatus: Scientific research and laboratory apparatus for drug screening or potency assays; cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue
- Class 042 — Scientific and technological services: Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; scientific and technological services and research in the field of regenerative medicine; cell culture services for scientific and research purposes, for others
Owner
- myriamed GmbH, DE
- myriamed GmbH, DE
- myriamed GmbH, DE
Prosecution history
- 23 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 31 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 30 Oct 2024 — FINAL DISPOSITION PROCESSED
- 07 Aug 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 06 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 06 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2024 — NOTIFICATION PROCESSED BY IB
- 20 Feb 2024 — PUBLISHED FOR OPPOSITION
- 07 Feb 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Feb 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 01 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED